0001683168-23-003078.txt : 20230509
0001683168-23-003078.hdr.sgml : 20230509
20230509171108
ACCESSION NUMBER: 0001683168-23-003078
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230505
FILED AS OF DATE: 20230509
DATE AS OF CHANGE: 20230509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cockroft Bettina M.
CENTRAL INDEX KEY: 0001900452
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39126
FILM NUMBER: 23903302
MAIL ADDRESS:
STREET 1: C/O ANNEXON, INC.
STREET 2: 180 KIMBALL WAY, SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001729427
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822318545
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: 1-800-946-9185
MAIL ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
4
1
ownership.xml
X0407
4
2023-05-05
0
0001729427
CNS Pharmaceuticals, Inc.
CNSP
0001900452
Cockroft Bettina M.
C/O CNS PHARMACEUTICALS, INC
100 WEST LOOP SOUTH, SUITE 900
HOUSTON
TX
77027
1
0
0
0
0
Option to purchase common stock
1.67
2023-05-05
4
A
0
8300
A
2023-05-05
Common Stock
8300
8300
D
The options set forth in this table vest in 36 equal monthly installments succeeding the issuance date, or May 5, 2023, subject to the grantee's
continued service on the Company's Board of Directors on each vesting date.
The options were issued in connection with the reporting person's Board of Director services to the Company.
/s/ Christopher Downs, Attorney-in-fact
2023-05-08